Chemical Works of Gedeon Richter. 

$41.38
102
+$1.17+2.9% Friday 15:33

Statistics

Day High
31
Day Low
31
52W High
45.28
52W Low
29
Volume
300
Avg. Volume
1,103
Mkt Cap
7.58B
P/E Ratio
9.58
Dividend Yield
5.18%
Dividend
2.14

Upcoming

Dividends

5.18%Dividend Yield
Jun 26
$2.14
Jun 25
$1.47
Jun 24
$1.18
Jun 23
$1.14
Jun 22
$0.60
10Y Growth
23.51%
5Y Growth
22.36%
3Y Growth
23.23%
1Y Growth
45.75%

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.99
1.02
1.04
1.07
Expected EPS
N/A
Actual EPS
N/A

Financials

24.9%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.72BRevenue
677.62MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RGEDF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that operates in the pharmaceuticals sector, directly competing with Gedeon Richter in various therapeutic areas.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a large pharmaceutical company with a wide range of products that compete with Gedeon Richter's offerings, especially in women's healthcare and central nervous system drugs.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a leading generic and specialty pharmaceutical company that competes with Gedeon Richter in the generics market and in developing specialty medicines.
Merck
MRK
Mkt Cap366B
Merck & Co. is a global healthcare company that develops medicines, vaccines, biologic therapies, and animal health products, competing with Gedeon Richter in several therapeutic areas.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in the pharmaceuticals industry, focusing on immunology, oncology, neuroscience, and virology, areas where Gedeon Richter also has significant interests.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines that compete with Gedeon Richter's product portfolio.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global healthcare leader that offers a broad range of pharmaceuticals, competing with Gedeon Richter in areas like central nervous system and cardiovascular diseases.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a science-led global healthcare company that competes with Gedeon Richter in developing and marketing medications and vaccines.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson is a diversified healthcare company that produces pharmaceuticals, medical devices, and consumer health products, competing across multiple segments with Gedeon Richter.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Gedeon Richter in developing new medicines in oncology, cardiovascular, renal & metabolism, and respiratory.

About

Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and anaesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, which are emergency contraceptive pills; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound healing; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergies; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; and Oralsept, a sore throat and local anesthetic. Further, it engages in the provision of financial accounting, social and welfare, portfolio and management, catering, carriage transportation, engineering, quality control, asset management, and biotechnological manufacturing and research services; pharmaceutical retail; trading of biotech products; and sale of medical equipment. The company has strategic co-development and license agreement with Adalvo Ltd. for a proposed bioequivalent to Semaglutide injection, a GLP-1 receptor agonist indicated for chronic weight management. Additionally, it has a strategic research collaboration with FimmCyte AG for the development of first-in-class antibody, ‘FMC2', for the treatment of endometriosis. The company was founded in 1901 and is headquartered in Budapest, Hungary.
Show more...
CEO
Gábor Orbán
Employees
11955
Country
Hungary
ISIN
HU0000123096
WKN
000A1W16N

Listings

0 Comments

Share your thoughts

FAQ

What is Chemical Works of Gedeon Richter. stock price today?
The current price of RGEDF is $41.38 USD — it has increased by +2.9% in the past 24 hours. Watch Chemical Works of Gedeon Richter. stock price performance more closely on the chart.
What is Chemical Works of Gedeon Richter. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Chemical Works of Gedeon Richter. stocks are traded under the ticker RGEDF.
Is Chemical Works of Gedeon Richter. stock price growing?
RGEDF stock has fallen by -4.32% compared to the previous week, the month change is a +8.86% rise, over the last year Chemical Works of Gedeon Richter. has showed a +41.47% increase.
What is Chemical Works of Gedeon Richter. market cap?
Today Chemical Works of Gedeon Richter. has the market capitalization of 7.58B
When is the next Chemical Works of Gedeon Richter. earnings date?
Chemical Works of Gedeon Richter. is going to release the next earnings report on November 10, 2026.
What is Chemical Works of Gedeon Richter. revenue for the last year?
Chemical Works of Gedeon Richter. revenue for the last year amounts to 2.72B USD.
What is Chemical Works of Gedeon Richter. net income for the last year?
RGEDF net income for the last year is 677.62M USD.
Does Chemical Works of Gedeon Richter. pay dividends?
Yes, RGEDF dividends are paid annual. The last dividend per share was 2.14 USD. As of today, Dividend Yield (FWD)% is 5.18%.
How many employees does Chemical Works of Gedeon Richter. have?
As of September 06, 2026, the company has 11,955 employees.
In which sector is Chemical Works of Gedeon Richter. located?
Chemical Works of Gedeon Richter. operates in the Health & Wellness sector.
When did Chemical Works of Gedeon Richter. complete a stock split?
The last stock split for Chemical Works of Gedeon Richter. was on July 11, 2013 with a ratio of 10:1.
Where is Chemical Works of Gedeon Richter. headquartered?
Chemical Works of Gedeon Richter. is headquartered in Budapest, Hungary.